No Detail Found!

Frequency of Bone Marrow Involvement in Different Stages of Diffuse Large B Cell Lymphoma (DLBCL).

Author(s)
Muhammad Sohaib Nadeem Combined Military Hospital, Rawalpindi, Pakistan
Naeem Haider Combined Military Hospital, Rawalpindi, Pakistan
Shahid Rasul Combined Military Hospital, Rawalpindi, Pakistan
Ujala Ali National University of Medical sciences, Rawalpindi, Pakistan
Muhammad Yousaf Khan Combined Military Hospital, Rawalpindi, Pakistan
Abstract
OBJECTIVE: To assess the frequency of bone marrow involvement in different stages of diffuse large B cell lymphoma patients. STUDY DESIGN: A cross sectional interventional study. PLACE AND DURATION: At Oncology Department of Combined Military Hospital Rawalpindi, from 15th Jan 2015 to 30th Oct 2015. METHODOLOGY: One hundred and twenty one patients were selected by purposive sampling technique. Diagnostic and staging work-up excluding bone marrow biopsy was done. Then all patients were subjected to the unilateral iliac bone marrow trephine biopsy. Samples were examined to see its invasion by lymphoma. Stage wise involvement of bone marrow was recorded and frequency of bone marrow involvement in different stages was calculated. RESULTS: Out of 121 patients, 33.8% were stage I, 30.6% stage II, 27.3% stage III and 8.3% were stage IV (excluding bone marrow examination). Stage wise involvement of bone marrow on trephine biopsy was 12%, 42%, 54% and 80% for stage I, II, III and IV respectively. Combined early stage (Stage I and II) patients had bone marrow involvement in 20% of cases. CONCLUSION: Stage wise bone marrow involvement in cases of diffuse large B cell lymphoma, is higher in patients presenting to our hospital, than reported in International literature. Exact cause of this increase in frequency should be determined by further studies.
Publication Details
Page(s) 212-215
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 10, Issue: 4, Year: 2018

Request the full text from PASTIC

References
JemalA,SiegelR,WardE,,2009,,CA Cancer J Clin,59,225-49
SwerdlowSH,CampoE,PileriSA,HarrisNL,SteinH,SiebertR,,2016,The 2016 revision of the World Health Organization classification of lymphoid neoplasms,Blood,127,2375-90
PerryAM,MitrovicZ,Wing C. Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma,,2012,,Cancer Control,19,214-26
LeeSJ,SuhCW,LeeS,KimWS,LeeWS,KimHJ,,2014,Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study,Korean J Intern Med,29,352-60
BukhariU,SabaJ,LateefF,,2015,Non-hodgkin's lymphoma - a study,Pak Oral & Dental J,35,412-15
MushtaqS,AkhterN,JamalS,MamoonN,KhadimT,SarfarazT,,2008,Malignant lymphoma in Pakistan according to WHO Classification of lymphoid neoplasms,Asian Pacific J Cancer Prev,,229-32
ZelenetzAD,AbramsonJS,AdvaniRH,AndreadisCB,BartlettN,BellamN,,2010,,Non-Hodgkin's Lymphomas: J Natl Compr Canc Netw,8,288-34
AminMB,EdgeS,GreeneF,ByrdDR,BrooklandRK,WashingtonMK,,2017,,AJCC Cancer Staging Manual (8th edition),,954-
ChungR,LaiR,WeiP,LeeJ,HansonJ,BelchAR,Blood,,2007,Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index,,110,1278-82
El BolkainyTM,Abo DeifWS,GoudaHM,MokhtarNM,,2008,Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity,J Egypt Natl Canc Inst,20,17-30
FendF,TzankovA,BinkK,SeidlS,QuintanillaML,KremerM,,2008,Modern techniques for the diagnostic evaluation of the trephine bone marrow biopsy: methodological aspects and applications,Prog Histochem Cytochem,42,203-52
AdamsHJA,KweeTC,,2015,Do not abandon the bone marrow biopsy yet in diffuse large B‐cell lymphoma,J Clin Oncol,33,1217-
Chen‐LiangTH,SantosTM,JerezA,GarcíaGR,SenentL,MillánCM,,2017,Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma,Cancer Med,6,2507-14
ZhouZ,SehnLH,RademakerAW,GordonLI,LaCasceAS,ThomsonAC,,2014,An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era,Blood,123,837-42
ParkY,ParkBB,JeongJY,KimWY,JangS,ShinBK,,2016,Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party;,Korean J Int Med,31,1030-41
ChesonBD,FisherRI,BarringtonSF,CavalliF,SchwartzLH,ZuccaE,,2014,Recommendations for initial evaluation, staging, and response assessment of Hodgkin and nonHodgkin lymphoma: the Lugano classification,J Clin Oncol,32,3059-68
BarringtonSF,MikhaeelNG,KostakogluL,MeignanM,HutchingsM,MüellerSP,,2014,Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group,J Clin Oncol,32,3048-58
ShiYF,LiXH,SongYQ,SongWW,LaiYM,,2015,Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China,Int J Clin Exp Pathol,8,7102-11
CampbellJK,MatthewsJP,SeymourJF,WolfMM,JunejaSK,,2003,Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma,Ann Oncol,14,273-76
KimB,LeeST,KimHJ,KimSH,,2015,Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma,Ann Lab Med,35,187-93
TalaulikarD,DalhstromJE,ShadboltB,BroomfieldA,McDonaldA,,2008,Role of immunohistochemistry in staging diffuse large B-cell lymphoma,J Histochem Cytochem,56,893-900
KittivorapartJ,ChinthammitrY,,2011,Incidence and risk factors of bone marrow involvement by non-Hodgkin lymphoma,J Med Assoc Thai,94,S239-45
SehnLH,ScottDW,ChhanabhaiM,BerryB,RuskovaA,BerkahnL,,2011,Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP,J Clin Oncol,29,1452-57
SovaniV,HarveyC,HaynesAP,McMillanAK,ClarkDM,O'Connor SR,,2014,Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings,J Clin Pathol,67,389-95
KumarS,RauAR,NaikR,KiniH,MathaiAM,PaiMR,,2009,Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study,Indian J Path Microbiol,52,332-38
0

Citations

0

Downloads

148

Views